Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease

BACKGROUND: Retrospective observational studies may provide real-world evidence about long-acting muscarinic receptor antagonist (LAMA) effectiveness in reducing mortality or COPD-related readmission risk after a COPD hospitalization. Causal inference and competing risk statistical procedures aid in...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberts, Melissa H., Mapel, Douglas W., Petersen, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060983/
https://www.ncbi.nlm.nih.gov/pubmed/31792873
http://dx.doi.org/10.1007/s40801-019-00171-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060983/
https://www.ncbi.nlm.nih.gov/pubmed/31792873
http://dx.doi.org/10.1007/s40801-019-00171-w

Ejemplares similares